Why Pfizer just made a $43 billion bet on a precise new way of attacking cancer

Tech Insider
pfizer

AP

Seagen's stock surges almost 11% after a report that Pfizer is in talks to buy the cancer-focused biotech

Tech Insider
pfizer

AP

The top doctor at a $2.7 billion pharma company developing a new depression drug says we may be 'on the cusp' of a new wave of mental-health treatments

Tech Insider
Sad young woman sitting on the window, watching out
Sad young woman sitting on the window, watching out - stock photo

Tunatura/Getty Images

Biotech CEO famous for spending millions to reverse age accused of walking out on ex after her breast cancer diagnosis and manipulating her in the spirit of 'radical transparency'

Tech Insider
Bryan Johnson
Bryan Johnson, a 45-year-old biotech founder, hopes to rewind the clock of his body a few decades through a program he started, called Project Blueprint.

Courtesy Dustin Giallanza

Depression treatments haven't changed much in decades. Here are the promising new drugs that could be more precise, work faster, and help more people.

Tech Insider
Digital art of colorful brain scan

Getty Images

Billion-dollar startup plans to bring the dodo back from the dead, and claims it can also revive the woolly mammoth

Tech Insider
An artist illustration shows a white dodo looking towards the camera on a white background.
Collossal Biosciences aims to revive the long-extinct dodo using gene editing.

David Tipling/Education Images/Universal Images Group via Getty Images

Subscribe to Biotech